Skip to content
777 Sourcing.

Capability

hIPSC-based disease models

Suppliers
1
States & provinces
1
Countries
1

1 hipsc-based disease models supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

AERYS BIOSCIENCES, INC.

PALO ALTO, CA

Aerys Biosciences is a clinical-stage biopharmaceutical company headquartered in Stanford Research Park, Palo Alto, California, spun out of Stanford University and Greenstone Biosciences. It develops next-generation small-molecule therapies for fibro-inflammatory lung diseases, including idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH), targeting mechanisms driving fibrosis and vascular remodeling.

drug repurposingearly-stage clinical trialshuman-relevant drug discoverypreclinical and translational studiessmall molecule therapeutic development

Compiled from public sources

Related capabilities

Other processes offered by the shops that list hIPSC-based disease models.

Browse all capabilities